| activating transcription factor 2 | ATF2 |
| adenomatous polyposis coli | APC |
| bicaudal-D2 | BICD2 |
| cullin 4B | CUL4B |
| DiGeorge syndrome critical region 8 | DGR8 |
| E2F transcription factor 4 | E2F4 |
| epithelial–mesenchymal transition | EMT |
| fibroblast growth factor 2 | FGF2 |
| high mobility group box 1 | HMGB1 |
| microRNAs | miRNAs |
| N-Myc downstream regulated 1 | NDRG1 |
| pygopus2 | Pygo2 |
| RNA-induced silencing complex | RISC |
| ribosomal protein S15A | RPS15A |
| secernin 1 | SRCIN1 |
| unc-51-like kinase1 complex | ULK1 |
| cancer stem cells | CSCs |
| cell adhesion molecule 1 | CADM1 |
| chaperon-mediated autophagy | CMA |
| epidermal growth factor | EGF |
| high-dose cytarabine | HDACi |
| hypoxia-inducible factor-1 | HIF-1a |
| lncRNA plasmacytoma variant translocation 1 | PVT1 |
| long noncoding RNA | lncRNA |
| lysosomal membrane protein 2A | LAMP-2A |
| mammalian target of rapamycin | mTOR |
| messenger RNA | mRNA |
| microsatellite instability | MSI-H |
| nuclear factor erythroid two like-2 | Nrf2 |
| pancreatic adenocarcinoma | PADC |
| phagophore assembly site | PAS |
| phosphatidylethanolamine | PE |
| phosphatidylinositol-3-phosphate | PtdIns3P |
| primary miRNA | pri-miRNA |
| reactive oxygen species | ROS |
| receptors for advanced glycation end products | RAGE |
| retinoblastoma-like protein 2 | RBL2 |
| ribonuclease complex Drosha | ribonuclease III |
| signal transducer and activator of transcription 3 | STAT3 |
| tumor microenvironment | TME |
| tumor protein, translationally controlled 1 | TPT1 |
| unfolded protein response | UPR |
| β-transducin repeat-containing protein | β-TrCP2 |